Thermosensitive nanosystems associated with hyperthermia for cancer treatment
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Institucional da UFMG |
Texto Completo: | https://doi.org/10.3390/ph12040171 http://hdl.handle.net/1843/56502 https://orcid.org/0000-0001-7750-036X https://orcid.org/0000-0001-6841-3061 https://orcid.org/0000-0003-1592-7936 https://orcid.org/0000-0003-3885-9374 https://orcid.org/0000-0003-4679-1891 https://orcid.org/0000-0002-7641-6585 https://orcid.org/0000-0001-8812-3811 |
Resumo: | Conventional chemotherapy regimens have limitations due to serious adverse effects. Targeted drug delivery systems to reduce systemic toxicity are a powerful drug development platform. Encapsulation of antitumor drug(s) in thermosensitive nanocarriers is an emerging approach with a promise to improve uptake and increase therapeutic efficacy, as they can be activated by hyperthermia selectively at the tumor site. In this review, we focus on thermosensitive nanosystems associated with hyperthermia for the treatment of cancer, in preclinical and clinical use. |
id |
UFMG_5a5614e9cb5e885a772dcfc106c71a9d |
---|---|
oai_identifier_str |
oai:repositorio.ufmg.br:1843/56502 |
network_acronym_str |
UFMG |
network_name_str |
Repositório Institucional da UFMG |
repository_id_str |
|
spelling |
Thermosensitive nanosystems associated with hyperthermia for cancer treatmentHyperthermiaThermosensitive systemsCancer treatmentCancer - TratamentoConventional chemotherapy regimens have limitations due to serious adverse effects. Targeted drug delivery systems to reduce systemic toxicity are a powerful drug development platform. Encapsulation of antitumor drug(s) in thermosensitive nanocarriers is an emerging approach with a promise to improve uptake and increase therapeutic efficacy, as they can be activated by hyperthermia selectively at the tumor site. In this review, we focus on thermosensitive nanosystems associated with hyperthermia for the treatment of cancer, in preclinical and clinical use.Universidade Federal de Minas GeraisBrasilFAR - DEPARTAMENTO DE ANÁLISES CLÍNICAS E TOXICOLÓGICASFAR - DEPARTAMENTO DE PRODUTOS FARMACÊUTICOSUFMG2023-07-17T20:27:58Z2023-07-17T20:27:58Z2019info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.3390/ph120401711424-8247http://hdl.handle.net/1843/56502https://orcid.org/0000-0001-7750-036Xhttps://orcid.org/0000-0001-6841-3061https://orcid.org/0000-0003-1592-7936https://orcid.org/0000-0003-3885-9374https://orcid.org/0000-0003-4679-1891https://orcid.org/0000-0002-7641-6585https://orcid.org/0000-0001-8812-3811porPharmaceuticalsIsabela Pereira GomesJaqueline Aparecida DuarteAna Luiza Chaves MaiaDomenico RubelloDanyelle M. TownsendAndré Luís Branco de BarrosElaine Amaral Leiteinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFMGinstname:Universidade Federal de Minas Gerais (UFMG)instacron:UFMG2023-07-17T20:27:58Zoai:repositorio.ufmg.br:1843/56502Repositório InstitucionalPUBhttps://repositorio.ufmg.br/oairepositorio@ufmg.bropendoar:2023-07-17T20:27:58Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)false |
dc.title.none.fl_str_mv |
Thermosensitive nanosystems associated with hyperthermia for cancer treatment |
title |
Thermosensitive nanosystems associated with hyperthermia for cancer treatment |
spellingShingle |
Thermosensitive nanosystems associated with hyperthermia for cancer treatment Isabela Pereira Gomes Hyperthermia Thermosensitive systems Cancer treatment Cancer - Tratamento |
title_short |
Thermosensitive nanosystems associated with hyperthermia for cancer treatment |
title_full |
Thermosensitive nanosystems associated with hyperthermia for cancer treatment |
title_fullStr |
Thermosensitive nanosystems associated with hyperthermia for cancer treatment |
title_full_unstemmed |
Thermosensitive nanosystems associated with hyperthermia for cancer treatment |
title_sort |
Thermosensitive nanosystems associated with hyperthermia for cancer treatment |
author |
Isabela Pereira Gomes |
author_facet |
Isabela Pereira Gomes Jaqueline Aparecida Duarte Ana Luiza Chaves Maia Domenico Rubello Danyelle M. Townsend André Luís Branco de Barros Elaine Amaral Leite |
author_role |
author |
author2 |
Jaqueline Aparecida Duarte Ana Luiza Chaves Maia Domenico Rubello Danyelle M. Townsend André Luís Branco de Barros Elaine Amaral Leite |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Isabela Pereira Gomes Jaqueline Aparecida Duarte Ana Luiza Chaves Maia Domenico Rubello Danyelle M. Townsend André Luís Branco de Barros Elaine Amaral Leite |
dc.subject.por.fl_str_mv |
Hyperthermia Thermosensitive systems Cancer treatment Cancer - Tratamento |
topic |
Hyperthermia Thermosensitive systems Cancer treatment Cancer - Tratamento |
description |
Conventional chemotherapy regimens have limitations due to serious adverse effects. Targeted drug delivery systems to reduce systemic toxicity are a powerful drug development platform. Encapsulation of antitumor drug(s) in thermosensitive nanocarriers is an emerging approach with a promise to improve uptake and increase therapeutic efficacy, as they can be activated by hyperthermia selectively at the tumor site. In this review, we focus on thermosensitive nanosystems associated with hyperthermia for the treatment of cancer, in preclinical and clinical use. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019 2023-07-17T20:27:58Z 2023-07-17T20:27:58Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://doi.org/10.3390/ph12040171 1424-8247 http://hdl.handle.net/1843/56502 https://orcid.org/0000-0001-7750-036X https://orcid.org/0000-0001-6841-3061 https://orcid.org/0000-0003-1592-7936 https://orcid.org/0000-0003-3885-9374 https://orcid.org/0000-0003-4679-1891 https://orcid.org/0000-0002-7641-6585 https://orcid.org/0000-0001-8812-3811 |
url |
https://doi.org/10.3390/ph12040171 http://hdl.handle.net/1843/56502 https://orcid.org/0000-0001-7750-036X https://orcid.org/0000-0001-6841-3061 https://orcid.org/0000-0003-1592-7936 https://orcid.org/0000-0003-3885-9374 https://orcid.org/0000-0003-4679-1891 https://orcid.org/0000-0002-7641-6585 https://orcid.org/0000-0001-8812-3811 |
identifier_str_mv |
1424-8247 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
Pharmaceuticals |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Federal de Minas Gerais Brasil FAR - DEPARTAMENTO DE ANÁLISES CLÍNICAS E TOXICOLÓGICAS FAR - DEPARTAMENTO DE PRODUTOS FARMACÊUTICOS UFMG |
publisher.none.fl_str_mv |
Universidade Federal de Minas Gerais Brasil FAR - DEPARTAMENTO DE ANÁLISES CLÍNICAS E TOXICOLÓGICAS FAR - DEPARTAMENTO DE PRODUTOS FARMACÊUTICOS UFMG |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFMG instname:Universidade Federal de Minas Gerais (UFMG) instacron:UFMG |
instname_str |
Universidade Federal de Minas Gerais (UFMG) |
instacron_str |
UFMG |
institution |
UFMG |
reponame_str |
Repositório Institucional da UFMG |
collection |
Repositório Institucional da UFMG |
repository.name.fl_str_mv |
Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG) |
repository.mail.fl_str_mv |
repositorio@ufmg.br |
_version_ |
1816829817216040960 |